You are here

Valeant to be led by group of senior execs as CEO on medical leave

[BENGALURU] Valeant Pharmaceuticals International Inc said a group of company executives will take over in an interim capacity, until CEO Michael Pearson returns from medical leave.

Pearson will be on a medical leave of absence, effective immediately, the company said in a statement on Monday.

Pearson was hospitalized with a "severe case of pneumonia"on Friday and is receiving treatment, a company spokeswoman said on Friday.

Valeant's board has created an "office of the Chief Executive Officer", which will include general counsel Robert Chai-Onn, company group chairman Ari Kellen, and chief financial officer Robert Rosiello.


Market voices on: